𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis

✍ Scribed by M. Davidson; P. D. Harvey; J. Vervarcke; C. A. Gagiano; J. D. De Hooge; G. Bray; M. Dose; Y. Barak; M. Haushofer

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
116 KB
Volume
15
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Multicenter, open-label study of recombi
Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease
✍ H. Karsten Harms; Elias Matouk; Guy Tournier; Horst von der Hardt; Peter H. Well πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 58 KB πŸ‘ 1 views

Cystic fibrosis is characterized by the accumulation of thick viscous purulent secretions. Recombinant human deoxyribonuclease I (rhDNase) breaks down extracellular DNA, which contributes to the increased viscosity of sputum. A multinational, open-label study was conducted in 974 cystic fibrosis pat

Reboxetine in the maintenance therapy of
Reboxetine in the maintenance therapy of depressive disorder in the elderly: a long-term open study
✍ Eugenio Aguglia πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 2 views

Depression in the elderly is often not recognised and is frequently under!treated[ Reboxetine is a selective nor! adrenaline reuptake inhibitor "selective NRI# which is e}ective and well tolerated in the treatment of depressed adult patients[ This prospective\ uncontrolled\ multicentre study was des

Safety and efficacy of a multicenter stu
Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors
✍ Nancy D. Doolittle; Michael E. Miner; Walter A. Hall; Tali Siegal; E. Jerome Han πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 309 KB πŸ‘ 2 views

The aim of this study was to determine the safety and efficacy of intraarterial chemotherapy with osmotic opening of the blood-brain barrier (BBB) for the treatment of malignant brain tumors when administered across multiple centers.